• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中医药治疗肺癌放化疗所致白血病的疗效:Meta 分析。

Effectiveness of Traditional Chinese Medicine on chemo-radiotherapy induced leukaemia in patients with lung cancer: a Meta-analysis.

机构信息

Respiratary Department of Pi Du District Hopspital of Traditional Chinese Medicine, Chengdu 611730, China.

Research Department of Pi Du District Hopspital of Traditional Chinese Medicine, Chengdu 611730, China.

出版信息

J Tradit Chin Med. 2018 Oct;38(5):661-667.

PMID:32185982
Abstract

OBJECTIVE

To assess the curative effect of Traditional Chinese Medicine (TCM) on leukopenia induced by chemo-radiotherapy in patients with lung cancer.

METHODS

A comprehensive electronic search in Medline, Embase, the Cochrane Libary database, China National Knowledge Infrastructure Database (CNKI) and Wanfang Database was conducted up to July 2017. Random-effects model was used to estimate the standardized mean differences (SMDs) with 95% confidence intervals (CIs). Eleven studies with a total of 957 patients were included in this meta-analysis.

RESULTS

The effectiveness in TCM group was higher than control group [RR = 1.60, 95% CI (1.38, 1.85), P < 0.000 01]. Compare with Western Medicine group, the effectiveness has no significant difference [RR = 0.96, 95% CI (0.82, 1.12), P = 0.57]. The ineffective rate in test group was lower than the control group [RR = 0.30, 95% CI (0.21, 0.42), P < 0.000 01].

CONCLUSION

By meta-regression it was suggested that TCM has curative effect on leukopenia induced by chemo-radiotherapy in patients with lung cancer, but by the influence of number and quality of researches, publication bias, more evidence from high quality studies, and larger cohorts for observational trials are needed.

摘要

目的

评估中医药治疗肺癌放化疗所致白细胞减少症的疗效。

方法

检索 Medline、Embase、Cochrane 图书馆、中国知网(CNKI)和万方数据库,检索时限均为 2017 年 7 月前。采用随机效应模型,计算标准化均数差(SMD)及其 95%置信区间(95%CI)。对纳入的 11 项研究进行荟萃分析,共 957 例患者。

结果

与对照组相比,中医药组的疗效更高[RR=1.60,95%CI(1.38,1.85),P<0.00001]。与西药组相比,中医药组的疗效无显著差异[RR=0.96,95%CI(0.82,1.12),P=0.57]。试验组的无效率低于对照组[RR=0.30,95%CI(0.21,0.42),P<0.00001]。

结论

荟萃回归分析表明,中医药对肺癌放化疗所致白细胞减少症有疗效,但受研究数量和质量、发表偏倚的影响,需要更多高质量研究和更大样本的观察性试验来进一步证实。

相似文献

1
Effectiveness of Traditional Chinese Medicine on chemo-radiotherapy induced leukaemia in patients with lung cancer: a Meta-analysis.中医药治疗肺癌放化疗所致白血病的疗效:Meta 分析。
J Tradit Chin Med. 2018 Oct;38(5):661-667.
2
Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.中药联合表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌:一项系统评价与Meta分析
J Integr Med. 2014 Jul;12(4):346-58. doi: 10.1016/S2095-4964(14)60034-0.
3
[Meta-analysis on effectiveness and safety of traditional Chinese medicine combined with first-generation EGFR-TKI in treating advanced non-small cell lung cancer].[中药联合第一代表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌的有效性和安全性的Meta分析]
Zhongguo Zhong Yao Za Zhi. 2017 Jul;42(13):2591-2598. doi: 10.19540/j.cnki.cjcmm.20170523.005.
4
Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trials.中药联合化疗治疗非小细胞肺癌(NSCLC)患者的疗效:一项随机临床试验的荟萃分析
Support Care Cancer. 2020 Aug;28(8):3571-3579. doi: 10.1007/s00520-020-05433-w. Epub 2020 Apr 7.
5
Efficacy and safety of TCM combined with chemotherapy for SCLC: a systematic review and meta-analysis.中医药联合化疗治疗小细胞肺癌的疗效和安全性:系统评价和荟萃分析。
J Cancer Res Clin Oncol. 2020 Nov;146(11):2913-2935. doi: 10.1007/s00432-020-03353-0. Epub 2020 Aug 14.
6
Can Aidi injection alleviate the toxicity and improve the clinical efficacy of radiotherapy in lung cancer?: A meta-analysis of 16 randomized controlled trials following the PRISMA guidelines.艾迪注射液能否减轻肺癌放疗的毒性并提高临床疗效?:一项遵循PRISMA指南的16项随机对照试验的荟萃分析。
Medicine (Baltimore). 2016 Aug;95(35):e4517. doi: 10.1097/MD.0000000000004517.
7
Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.CIK 联合放疗治疗肺癌的临床疗效和安全性:16 项随机对照试验的荟萃分析。
Int Immunopharmacol. 2018 Aug;61:363-375. doi: 10.1016/j.intimp.2018.06.012. Epub 2018 Jun 23.
8
Oral traditional Chinese medication for adhesive small bowel obstruction.口服中药治疗粘连性小肠梗阻。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008836. doi: 10.1002/14651858.CD008836.pub2.
9
Systematic review of randomized controlled trials of traditional Chinese medicine treatment of non-acute bronchial asthma complicated by gastroesophageal reflux.系统评价中医药治疗非急性支气管哮喘合并胃食管反流的随机对照试验。
J Tradit Chin Med. 2012 Mar;32(1):12-8. doi: 10.1016/s0254-6272(12)60025-9.
10
Can Aidi injection improve overall survival in patients with non-small cell lung cancer? A systematic review and meta-analysis of 25 randomized controlled trials.艾迪注射液能否提高非小细胞肺癌患者的总生存期?25 项随机对照试验的系统评价和荟萃分析。
Complement Ther Med. 2018 Apr;37:50-60. doi: 10.1016/j.ctim.2018.01.011. Epub 2018 Jan 31.

引用本文的文献

1
Treatment of Lung Cancer with Orally Administered Chinese Herbal Medicine: An Evidence Map between 1970-2020.2020 年 1970 年至口服中药治疗肺癌:证据图谱。
Chin J Integr Med. 2022 Oct;28(10):930-938. doi: 10.1007/s11655-022-3465-3. Epub 2022 Mar 3.
2
Chinese Herbal Medicine for Chemotherapy-Induced Leukopenia: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials.中药治疗化疗所致白细胞减少症:高质量随机对照试验的系统评价与Meta分析
Front Pharmacol. 2021 May 4;12:573500. doi: 10.3389/fphar.2021.573500. eCollection 2021.